We are live on ! Find out more
PWM

Palumbo Wealth Management Portfolio holdings

AUM $410M
1-Year Est. Return 32.56%
This Fund
S&P 500
This Quarter Est. Return
+3.99%
1 Year Est. Return
+32.56%
3 Year Est. Return
+80.66%
5 Year Est. Return
+99.66%
10 Year Est. Return
AUM
$268M
AUM Growth
+$10.7M
Cap. Flow
+$8.24M
Cap. Flow %
3.08%
Top 10 Hldgs %
44.03%
Holding
194
New
34
Increased
97
Reduced
35
Closed
19

Sector Composition

Rank Sector Weight
1 Technology 15.76%
2 Financials 7.1%
3 Consumer Discretionary 6.87%
4 Healthcare 6.71%
5 Industrials 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRTO icon
151
Criteo S.A. Ordinary Shares
CRTO
$1.13B
$208K 0.08%
+5,264
New +$210K
BIB icon
152
ProShares Ultra NASDAQ Biotechnology
BIB
$81.1M
$203K 0.08%
4,000
ECL icon
153
Ecolab
ECL
$79.7B
$201K 0.08%
859
+42
+5% +$10.4K
ABR icon
154
Arbor Realty Trust
ABR
$974M
$200K 0.07%
14,448
+408
+3% +$6.01K
PHVS icon
155
Pharvaris
PHVS
$2.37B
$196K 0.07%
+10,221
New +$210K
ASMB icon
156
Assembly Biosciences
ASMB
$524M
$180K 0.07%
+11,427
New +$184K
ASRT
157
DELISTED
Assertio
ASRT
$179K 0.07%
13,707
+1,310
+11% +$19.5K
NUVB icon
158
Nuvation Bio
NUVB
$2.24B
$174K 0.06%
65,360
+48,914
+297% +$126K
MDXG icon
159
MiMedx Group
MDXG
$622M
$171K 0.06%
+17,785
New +$139K
FNA
160
DELISTED
Paragon 28, Inc.
FNA
$171K 0.06%
+16,553
New +$134K
TMCI icon
161
Treace Medical Concepts
TMCI
$307M
$166K 0.06%
22,259
+9,263
+71% +$62K
ZUO
162
DELISTED
Zuora, Inc.
ZUO
$160K 0.06%
16,152
+4,616
+40% +$44.8K
PATH icon
163
UiPath
PATH
$7.31B
$144K 0.05%
+11,337
New +$150K
DNA icon
164
Ginkgo Bioworks
DNA
$612M
$144K 0.05%
+14,631
New +$125K
NPCE icon
165
Neuropace
NPCE
$482M
$129K 0.05%
+11,517
New +$100K
MTTR
166
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$124K 0.05%
26,073
+10,341
+66% +$49.1K
OCUL icon
167
Ocular Therapeutix
OCUL
$1.89B
$99.9K 0.04%
+11,693
New +$114K
ARDX icon
168
Ardelyx
ARDX
$1.24B
$86.4K 0.03%
17,041
-3,485
-17% -$19.3K
OABI icon
169
OmniAb
OABI
$290M
$75.1K 0.03%
21,204
-3,436
-14% -$13.6K
ERAS icon
170
Erasca
ERAS
$6.38B
$71.8K 0.03%
28,600
-11,123
-28% -$30.5K
ORGO icon
171
Organogenesis Holdings
ORGO
$305M
$64.6K 0.02%
+20,190
New +$67.7K
INZY
172
DELISTED
Inozyme Pharma
INZY
$64.5K 0.02%
23,281
+7,995
+52% +$30.4K
VTYX
173
DELISTED
Ventyx Biosciences
VTYX
$52.4K 0.02%
23,932
+11,792
+97% +$26.7K
NAUT icon
174
Nautilus Biotechnolgy
NAUT
$125M
$47.8K 0.02%
28,475
+8,888
+45% +$21.3K
ELEV
175
DELISTED
Elevation Oncology
ELEV
$38.9K 0.01%
69,105
+51,590
+295% +$30.5K

Similar funds

Palumbo Wealth Management's Q4 2024 Portfolio in Review

As of Q4 2024, Palumbo Wealth Management held 194 positions worth $268M, up 4.1% from $257M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Palumbo Wealth Management deployed $8.24M of net new capital in Q4 2024, opening 34 new positions and adding to 97 existing holdings. Its largest new stake was JPMorgan Ultra-Short Income ETF: 414,088 shares worth $20.9M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares TIPS Bond ETF, an estimated $5.44M trimmed.

  • Palumbo Wealth Management's largest Q4 2024 buy was JPMorgan Ultra-Short Income ETF: 414,088 shares worth $20.9M.
  • Palumbo Wealth Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $6.69M increase.
  • Palumbo Wealth Management's biggest Q4 2024 reduction was iShares TIPS Bond ETF, cutting an estimated $5.44M.
  • Palumbo Wealth Management fully exited iShares 20+ Year Treasury Bond ETF in Q4 2024, selling an estimated $12.7M.
  • Palumbo Wealth Management's ten largest holdings make up 44% of its $268M portfolio in Q4 2024.
  • Palumbo Wealth Management opened 34 new positions and closed 19 in Q4 2024.
  • Palumbo Wealth Management's portfolio value rose 4.1% quarter-over-quarter to $268M.

Based on Palumbo Wealth Management's 13F filing for Q4 2024, filed 30 Jan 2025.